Measuring Cell Free Tumor DNA (cfDNA) Levels in Blood and Cerebrospinal Fluid Before, During, and After First-Line Chemotherapy for Primary Central Nervous System Lymphoma

Measuring Cell Free Tumor DNA (cfDNA) Levels in Blood and Cerebrospinal Fluid Before, During, and After First-Line Chemotherapy for Primary Central Nervous System Lymphoma
Condition:   Primary Central Nervous System Lymphoma (PCNSL)
Intervention:   Drug: Nivolumab
Sponsors:   Memorial Sloan Kettering Cancer Center;   Bristol-Myers Squibb
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 27, 2020 / by / in
Comments